Biomerica, Inc. BMRA
NASDAQ
| 08/31/2026 | 05/31/2026 | 02/28/2026 | 11/30/2025 | 08/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -11.20% | -16.17% | -23.81% | -20.05% | -11.31% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -11.20% | -16.17% | -23.81% | -20.05% | -11.31% |
| Cost of Revenue | 1.18% | -14.93% | -15.75% | -15.49% | -15.41% |
| Gross Profit | -93.87% | -28.14% | -75.56% | -58.12% | 31.13% |
| SG&A Expenses | 2.29% | 6.09% | -2.55% | -12.83% | -19.20% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -0.01% | -6.43% | -10.19% | -15.19% | -18.67% |
| Operating Income | -11.18% | -3.64% | -4.98% | 10.60% | 24.89% |
| Income Before Tax | -36.40% | 24.50% | 14.30% | 28.20% | 40.48% |
| Income Tax Expenses | 2,400.00% | 1,000.00% | 425.00% | -25.00% | -95.65% |
| Earnings from Continuing Operations | -37.05% | 24.09% | 13.94% | 28.19% | 40.68% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -37.05% | 24.09% | 13.94% | 28.19% | 40.68% |
| EBIT | -11.18% | -3.64% | -4.98% | 10.60% | 24.89% |
| EBITDA | -11.67% | -3.90% | -5.13% | 10.73% | 25.28% |
| EPS Basic | -0.29% | 44.20% | 28.76% | 38.37% | 44.45% |
| Normalized Basic EPS | -2.07% | 5.48% | 10.31% | 22.63% | 29.96% |
| EPS Diluted | -0.96% | 43.83% | 28.86% | 38.58% | 44.68% |
| Normalized Diluted EPS | -2.07% | 5.48% | 10.31% | 22.63% | 29.96% |
| Average Basic Shares Outstanding | 31.26% | 31.78% | 23.07% | 20.13% | 11.54% |
| Average Diluted Shares Outstanding | 31.26% | 31.78% | 23.07% | 20.13% | 11.54% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |